FIRRM and urinary bladder carcinoma: High C1ORF112 mRNA expression has been previously reported in breast cancer (Leo et al., 2005), gastric cancer (Chen et al., 2020), desmoid tumors (Bowden et al., 2007), bladder cancer (Sanchez-Carbayo et al., 2007), head and neck squamous cell carcinoma (Renkonen et al., 2017), cervical cancer, and others.